Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraduodenal Delivery of Viokase 16 in Chronic Pancreatitis with EPI
NCT00559052Phase 2Completed
- Sponsor
- Axcan Pharma Inc.
- Start
- Mar 2008
- Primary completion
- Feb 2009
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by Axcan Pharma Inc.. Started Mar 2008; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT00559052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00559052.